Follow

Initiator Pharma A/S

Nasdaq First North GM Stockholm (Sweden)

Initiator Pharma main focus is to develop drug candidates to be used in treatment of erectile dysfunction in men.
Go to market

Sector:
HEALTH CARE
Media
Rights issue
Price
7.50 SEK
Subscription period
16 Jun - 30 Jun 2022
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
INIT
DK0060775872
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Initiator Pharma A/S with ticker INIT
Status
Active
Amount of instruments
43 772 462
Currency
SEK
First trading date
16 Mar 2017
Rights issue
Sign in to buy
Exercise
Sign in to buy
Remuneration issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Directed issue
Sign in to buy
Type
Price
Pre-money
Time
Files
Rights issue
7.50 SEK
328.29M SEK
16 Jun - 30 Jun 2022
Share issue in Initiator Pharma A/S
Type
Ticker
ISIN
Market
SHARE
INIT
DK0060775872
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Initiator Pharma A/S with ticker INIT
Status
Active
Amount of instruments
43 772 462
Currency
SEK
First trading date
16 Mar 2017
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Directed issue
Sign in to buy
Type
Price
Pre-money
Time
Files
Rights issue
7.50 SEK
328.29M SEK
16 Jun - 30 Jun 2022
Share issue in Initiator Pharma A/S
Type
Ticker
ISIN
Market
OPTION
INIT TO1
DK0060954881
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Initiator Pharma A/S with ticker INIT TO1
Status
Archived
Amount of instruments
5 789 294
Currency
SEK
Trading period
03 May 2018 - 30 Oct 2018
Terms
One (1) Unit consists of three (3) shares and two (2) free of charge warrants of series TO1. One (1) warrant entitles the holder to subscribe for one (1) new share for SEK 2.20 during the period October 11, 2018 - November 1, 2018.
Update (25.04.2018): Trading in warrants of series TO1 begins on May 3, 2018.
Update (11.10.2018): Subscription period with the support of warrants TO1 begins today.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
INIT TO2
DK0061282977
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Initiator Pharma A/S with ticker INIT TO2
Status
Archived
Amount of instruments
3 355 099
Currency
SEK
Trading period
14 Jul 2020 - 11 Dec 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 4.90 during the period ber 24, 2020 - December 15, 2020.
Update (02.07.2020): First day of trading in warrants of series TO2.
Update (10.12.2020): Last day of trading in warrants of series TO2.
Exercise
Sign in to buy
People
Claus Elsborg Olesen
CEO
Magnus Persson
Chairman of the board
Anette Collin
Board member
Claus Elsborg Olesen
Board member
Henrik Moltke
Board member
Peter Holm
Board member
Company Details
Sector
HEALTH CARE

Address
Lyngsievej 18
Zip code
8230
City/district
Åbyhøj
Country
Denmark (DK)
Registration number
37663808
LEI code
213800DFI4I1A5RVKB59
First trade date
16 Mar 2017
Registration date
02 May 2016
Short name
IP

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More